Operating income decreased 148.1%
Operating income changed -148.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -148.1% from the comparable as-filed period.
Gross margin changed -4505 basis points from the comparable as-filed period.
Net income changed -84.8% from the comparable as-filed period.
Operating margin changed -9518 basis points from the comparable as-filed period.
Revenue changed -30.5% from the comparable as-filed period.
Gross profit changed -89.0% from the comparable as-filed period.
Research & development changed +66.8% from the comparable as-filed period.
Total assets changed -29.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +37.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed +251.5% from the comparable as-filed period.
Trade receivables changed -42.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.